bat
belong
one
abund
divers
wide
distribut
mammalian
group
order
chiroptera
divid
two
subord
megachiroptera
microchiroptera
total
speci
yet
describ
bat
evolv
earli
chang
littl
past
million
year
wide
distribut
migratori
behaviour
favour
bat
vector
virus
rais
concern
role
zoonot
diseas
among
larg
number
virus
detect
bat
like
hendra
viru
nipah
viru
sever
acut
respiratori
syndrom
coronaviru
sar
ebola
viru
west
nile
viru
report
zoonot
also
lyssavirus
except
mokola
viru
ikoma
lyssaviru
detect
bat
north
america
bat
host
rabv
wherea
europ
european
bat
lyssaviru
type
found
differ
bat
speci
annual
approxim
human
death
caus
rabi
especi
develop
countri
asia
africa
despit
human
rabi
death
associ
dog
rabi
directli
link
contact
bat
human
rabi
case
bat
origin
america
human
case
caus
eblv
report
europ
date
although
bat
associ
virus
caus
sever
diseas
variou
mammal
seem
less
pathogen
bat
experiment
infect
hendra
nipah
viru
bat
show
clinic
diseas
guinea
pig
succumb
dose
viru
similar
situat
also
observ
hendra
viru
infect
hors
bat
lyssavirus
virus
report
caus
clinic
diseas
bat
howev
small
proport
bat
develop
clinic
symptom
experiment
infect
indic
critic
differ
develop
viral
diseas
bat
mammal
requir
profound
investig
bat
immunolog
hostviru
interact
sinc
identifi
european
bat
speci
endang
strictli
protect
use
anim
trial
investig
immun
mechan
bat
possibl
thu
develop
stabl
cell
line
vitro
studi
deriv
european
bat
speci
desir
far
sever
bat
cell
line
report
previou
studi
establish
noneuropean
bat
like
tadarida
brasiliensi
mviit
myoti
velif
incautu
sever
primari
immort
cell
line
pteropu
alecto
carollia
perspicillata
eidolon
helvum
rousettu
aegyptiacu
viral
infect
studi
carri
fruit
bat
cell
line
investig
suscept
infect
kinet
henipaviru
well
host
innat
immun
howev
suscept
lyssaviru
yet
examin
cell
line
addit
except
brain
cell
line
eptesicu
serotinu
employ
investig
type
interferon
ifn
respons
lyssaviru
infect
use
bat
cell
line
tool
studi
lyssaviru
infect
natur
reservoir
host
rare
broader
varieti
bat
cell
line
particularli
european
bat
cell
line
tissu
immun
relev
therefor
urgent
demand
lyssavirushost
studi
studi
establish
differ
cell
line
european
bat
myoti
evalu
suscept
rabv
infect
investig
innat
immun
gene
respons
polyinosin
polycytidyl
acid
poli
c
stimul
establish
myoti
cell
line
present
valuabl
vitro
model
studi
interact
lyssavirus
natur
host
shed
light
mechan
resist
bat
central
nervou
system
cn
ethic
approv
captur
sampl
confirm
compet
author
respect
feder
republ
germani
czech
republ
czech
academi
scienc
ethic
committe
review
approv
anim
use
protocol
complianc
law
protect
anim
cruelti
adopt
parliament
czech
republ
captur
sampl
myoti
specimen
moravian
karst
novemb
complianc
law
natur
landscap
protect
base
permit
issu
natur
conserv
agenc
czech
republ
establish
myoti
cell
line
singl
sacrif
specimen
use
examin
bat
respons
infect
pseudogymnoascu
destructan
unpublish
data
well
present
studi
rabi
three
coauthor
present
manuscript
concern
establish
myoti
cell
line
investig
lyssaviru
infect
ie
hana
bandouchova
jiri
pikula
jan
zukal
examin
whitenos
syndrom
czech
republ
hold
necessari
permit
paper
base
permit
excempt
law
natur
landscap
protect
czech
republ
allow
euthanasia
myoti
bat
alreadi
publish
singl
myoti
male
captur
sloupskososuvsk
cave
moravian
karst
czech
republ
coordin
bat
kept
minim
stress
handl
captur
euthanasia
clean
plastic
box
soft
mesh
enabl
roost
temperatur
hibern
torpor
transfer
laboratori
veterinari
pharmaceut
scienc
brno
czech
republ
within
day
anesthet
insensit
use
isofluranum
isofluran
piram
healthcar
uk
euthan
decapit
subject
necropsi
order
collect
organ
tissu
tissu
freshli
isol
euthan
bat
minc
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
fc
penicillin
unitsml
streptomycin
mgml
sigma
primari
cell
cultur
plate
till
confluenc
reach
immort
done
transfect
plasmid
express
simian
vacuol
viru
larg
antigen
lipofectamin
accord
protocol
invitrogen
immort
cell
expand
stock
frozen
sever
passag
mrna
express
establish
line
test
revers
transcript
pcr
rtpcr
use
specif
primer
protein
express
control
immunofluoresc
western
blot
describ
briefli
cell
first
fix
paraformaldehyd
permeabil
triton
x
wash
pb
cell
stain
mous
monoclon
antibodi
santa
cruz
biotechnolog
goat
antimous
igg
alexa
fluor
invitrogen
second
antibodi
visual
fluoresc
microscop
western
blot
mous
antibodi
use
primari
antibodi
bound
antibodi
detect
goat
antimous
igg
peroxidas
sigma
imag
develop
use
ecl
kit
thermo
scientif
pierc
accord
manufactur
instruct
confirm
ident
establish
myoti
cell
line
deriv
brain
cerebrum
design
mmbr
tonsil
mmto
periton
caviti
mmpca
nasal
epithelium
mmnep
nervu
olfactoriu
mmnol
myotisspecif
pcr
develop
nadh
dehydrogenas
subunit
gene
genbank
access
number
myoti
use
speci
specif
molecular
marker
genom
dna
differ
cell
line
isol
dneasi
blood
tissu
kit
qiagen
concentr
puriti
genom
dna
determin
nanodrop
thermo
pcr
perform
use
specif
primer
pair
tabl
genom
dna
templat
gotaq
flexi
dna
polymeras
promega
get
fragment
pcr
product
clone
vector
invitrogen
transform
e
coli
compet
cell
plasmid
extract
posit
clone
sequenc
appli
biosystem
genet
analyz
life
technolog
friedrichloefflerinstitut
germani
evalu
ifn
respons
myoti
cell
line
induct
ifn
mediat
signal
poli
c
use
stimul
cell
differ
cell
line
seed
plate
densiti
rang
cellswel
cultur
describ
around
hour
seed
cell
transfect
poli
c
sigma
concentr
lipofectamin
invitrogen
follow
manufactur
instruct
twenti
four
hour
post
stimul
cell
harvest
rlt
buffer
qiagen
rna
extract
rneasi
mini
kit
qiagen
earli
immort
third
passag
immort
cell
line
use
check
infect
rabv
cell
infect
rabv
european
fox
isol
fuse
green
fluoresc
protein
gfp
moi
twenti
four
hour
post
infect
hpi
infect
cell
fix
permeabil
describ
visual
fluoresc
microscop
mmbr
mmto
cell
infect
serial
moi
harvest
hpi
use
rna
extract
confirm
infect
later
passag
cell
differ
immort
cell
line
passag
infect
lyssavirus
rabv
e
serotinu
isol
daubentonii
isol
moi
infect
cell
cultur
describ
cell
collect
rna
extract
hpi
quantit
realtim
pcr
qrtpcr
perform
touchdetect
system
biorad
use
sensifast
sybr
onestep
kit
biolin
accord
protocol
immunofluoresc
analysi
perform
fix
cell
use
fitc
conjug
antirabi
monoclon
antibodi
sifin
hpi
describ
confirm
suscept
mmbr
mmnol
cell
line
infect
moi
set
sensit
ct
valu
inocul
dose
viral
supernat
either
chang
chang
fresh
medium
hpi
viral
replic
level
measur
qrtpcr
hpi
qrtpcr
introduc
measur
mrna
express
level
immun
relat
molecul
respons
poli
c
stimul
viru
infect
select
molecul
includ
ifn
induc
gene
ifn
stimul
gene
myxoviru
resist
ifn
induc
protein
tetratricopeptid
repeat
pattern
recognit
receptor
prr
tolllik
receptor
retino
acidinduc
gene
melanoma
differentiationassoci
protein
primer
design
base
sequenc
resourc
unpublish
sequenc
databas
public
databas
bat
speci
softwar
primer
design
includ
primer
premier
onlin
tool
http
http
wwwncbinlmnihgovtoolsprimerblast
primer
target
gene
intern
control
list
tabl
qrtpcr
perform
touchdetect
system
biorad
use
sensifast
sybr
onestep
kit
biolin
accord
protocol
assess
specif
pcr
amplif
melt
curv
analysi
perform
end
reaction
rel
express
level
target
calcul
method
molecular
character
mmbrbecaus
mmbr
deriv
cn
target
fatal
infect
lyssavirus
character
cell
type
mmbr
desir
improv
understand
antivir
defens
cn
express
cluster
differenti
cd
marker
cell
macrophag
lineag
marker
express
activ
microglia
investig
rtpcr
differ
cell
line
specif
primer
intern
control
list
tabl
rtpcr
prepar
accord
instruct
onestep
rtpcr
kit
qiagen
data
present
mean
sd
statist
signific
differ
analys
oneway
anova
use
spss
softwar
packag
five
myoti
cell
line
brain
mmbr
tonsil
mmto
periton
caviti
mmpca
nasal
epithelium
mmnep
nervu
olfactoriu
mmnol
success
establish
transform
gene
integr
chromosom
dna
vari
cell
morpholog
observ
cell
line
mmbr
mmto
mmnep
mmnol
fibroblasticlik
mmpca
epitheliallik
fig
mrna
express
antigen
detect
cell
line
fig
protein
level
express
confirm
four
five
cell
line
immunofluoresc
microscopi
western
blot
respect
fig
mmto
protein
level
antigen
detect
transcript
level
significantli
low
determin
rtpcr
fig
immort
five
cell
line
grew
passag
ident
cell
line
valid
myoti
specif
pcr
use
gene
molecular
marker
predict
fragment
obtain
genom
dna
cell
line
confirm
sequenc
first
step
toward
character
innat
immun
compet
differ
cell
line
perman
induc
express
molecul
involv
cell
autonom
respons
examin
prr
display
variou
distribut
pattern
differ
cell
line
fig
note
mmbr
lowest
level
fig
higher
mrna
level
p
observ
mmto
mmpca
mmnep
mmnol
compar
mmbr
respect
mmto
mmnep
mmpca
mmnol
p
higher
express
level
measur
fig
addit
time
higher
express
level
shown
cell
line
compar
mmbr
p
fig
investig
focus
express
induc
poli
c
stimul
fig
obtain
result
indic
mmbr
mmnep
mmnol
mmpca
p
increas
express
whilst
chang
mmto
fig
ifn
induc
gene
upregul
differ
extent
differ
cell
line
fig
c
e
detail
express
increas
mmbr
high
mmnol
p
fig
express
rang
time
time
mmto
mmbr
respect
fig
upregul
time
mmto
mmnol
respect
p
fig
natur
reservoir
speci
main
advantag
perman
myoti
cell
line
suscept
lyssaviru
infect
earli
stage
immort
cell
line
display
signific
suscept
rabv
moi
hpi
demonstr
infect
gfp
fuse
rabv
notabl
mmbr
exhibit
consider
lower
viral
load
compar
cell
line
fig
later
passag
immort
cell
line
show
suscept
rabv
differ
extent
fig
b
gener
mmbr
cell
line
present
lower
sensit
three
lyssavirus
moi
four
cell
line
measur
qrtpcr
hpi
fig
monitor
immunofluoresc
hpi
fig
thu
suscept
could
order
mmnol
mmnep
fulli
suscept
high
replic
rate
mmpca
mmto
suscept
much
less
viral
replic
mmbr
suscept
rabv
low
viral
replic
singl
infect
cell
infect
fig
differ
suscept
cell
line
lyssaviru
infect
confirm
growth
kinet
two
repres
model
mmbr
much
less
suscept
mmnol
highli
suscept
fig
evalu
cell
line
model
studi
differ
suscept
mmbr
cell
line
mrna
express
prr
ifn
induc
gene
investig
mmto
mmbr
rabv
infect
moi
express
three
prr
remain
mostli
unchang
mmto
significantli
regul
mmbr
increas
express
increas
express
moi
p
fig
compar
express
pattern
observ
nearli
upregul
mmto
display
dose
depend
increas
mmbr
along
increas
moi
especi
fig
mrna
level
increas
time
time
infect
mmbr
p
microglia
macrophagelik
cell
resid
immun
effector
cell
cn
activ
respons
infect
injuri
play
central
role
immun
surveil
host
defens
rtpcr
result
show
express
mmbr
four
cell
line
fig
suggest
mmbr
microgliaderiv
cell
line
cell
autonom
innat
immun
mechan
first
line
defens
viral
infect
mediat
mainli
prr
machineri
ifn
ifn
induc
effector
molecul
viral
pathogen
like
lyssavirus
develop
evas
strategi
escap
host
defens
counteract
ifn
mediat
immun
respons
coevolut
lyssavir
evad
bat
protect
mechan
result
optim
balanc
protect
bat
natur
host
sever
clinic
symptom
death
bat
chang
littl
past
million
year
illustr
phenomenon
well
resist
lethal
diseas
caus
virus
mammal
understand
specif
hostpathogen
interact
natur
host
like
bat
studi
bat
perform
howev
due
strict
protect
endang
european
bat
speci
vitro
model
use
studi
success
establish
five
myoti
cell
line
deriv
neural
immun
relat
tissu
ensur
suitabl
cell
line
analyz
virushost
cell
interact
suscept
infect
well
presenc
correspond
defens
pathway
confirm
first
exist
viral
sensor
perman
cell
line
suggest
capac
cell
line
sens
broad
rang
rna
virus
increas
express
dsrna
receptor
ifn
induc
gene
stimul
poli
c
mimick
viral
infect
indic
cell
line
use
effect
vitro
model
studi
bat
innat
immun
respons
viru
infect
furthermor
serv
valuabl
model
would
vari
suscept
cell
line
infect
lyssavirus
present
studi
differ
suscept
observ
differ
myoti
cell
line
use
rabv
might
relat
differ
capac
cell
line
produc
antivir
mediat
control
infect
moreov
strong
differ
suscept
rabv
infect
mmbr
cell
line
provid
uniqu
opportun
compar
investig
cell
autonom
innat
immun
mechan
reservoir
host
addit
lyssavirus
member
rhabdovirida
famili
like
vesicular
stomat
viru
vsv
also
investig
use
model
futur
studi
preliminari
result
indic
correl
observ
vari
suscept
abil
upregul
prr
ifn
induc
gene
emerg
evid
shown
prr
play
pivot
role
antivir
immun
cn
brain
deriv
cell
line
mmbr
high
upregul
reveal
activ
rigilik
receptor
pathway
rabv
infect
previous
report
major
prr
induc
ifn
rabv
infect
cell
may
function
sustain
ifn
induct
increas
express
ifn
induc
gene
mmbr
indic
product
ifn
induc
activ
contrast
low
express
level
impli
vagu
involv
antirabv
infect
immun
resist
shown
particip
benefit
rabv
pathogenesi
human
neuron
cell
howev
role
rabv
infect
bat
need
investig
importantli
signific
express
pattern
prr
observ
present
cell
line
model
provid
access
issu
vitro
reach
success
infect
virus
must
overcom
barrier
innat
immun
system
report
ifn
product
signal
pathway
antagon
p
alecto
cell
line
henipaviru
infect
similarli
recent
studi
show
limit
express
type
ifn
ifn
induc
gene
lyssavirus
infect
e
serotinu
brain
cell
line
correl
low
viral
load
high
express
level
ifn
induc
gene
mmbr
contrast
high
viral
load
silent
express
pattern
antivir
effector
mmto
provid
evid
countermeasur
ifn
system
lyssaviru
peripher
tissu
versu
protect
mechan
infect
brain
tissu
bat
microgli
cell
one
major
cell
popul
brain
tissu
addit
compar
neuron
infect
differ
rabv
strain
lesser
extent
presenc
well
antilyssaviru
respons
mmbr
support
microglialik
featur
mmbr
cn
report
mous
microglia
cell
line
activ
strong
innat
immun
rabv
infect
robust
immun
respons
microglialik
mmbr
demonstr
critic
role
microglia
antirabi
defens
bat
cn
addit
function
microglia
clearanc
infect
virus
cn
requir
systemat
respons
complex
interact
differ
brain
resid
cell
herein
establish
identif
microglialik
cell
model
first
step
toward
understand
complex
reaction
cn
respons
lyssaviru
infect
reservoir
speci
overal
preliminari
studi
use
establish
cell
line
impli
immun
mechan
control
viru
replic
present
cn
bat
seem
abil
control
pathogen
rabv
replic
via
ifn
system
cn
contribut
asymptomat
outcom
bat
conclus
establish
immort
cell
line
european
bat
myoti
display
variabl
suscept
differ
lyssavirus
serv
use
model
studi
virushost
interact
antivir
resist
mechan
natur
lyssaviru
host
studi
provid
preliminari
insight
antivir
innat
immun
correl
cn
neurotrop
virus
infect
bat
